Finance September 24, 2025

Does Eli Lilly's New $5 Billion Drug Manufacturing Facility Make It a Long-Term Buy?

newsfeedback@fool.com (Eric Volkman)

Eli Lilly (NYSE: LLY) is a pharmaceutical manufacturer, not a construction business. And yet construction has been a focal point of late, given that it's planning a set of new factories. It's devoting $5 billion or so to the first one, a big investment even for such a large company.Let's take a brief look at this venture and see what effect it might have on Eli Lilly investors.In mid-September, Eli Lilly formally announced the building project, which will rise just west of Richmond, Virginia. The factory will be used to produce products such as antibody-drug conjugates (a type of targeted medication that is delivered directly to cells affected by a particular disease). Continue reading

More from Motley Fool
AMD-OpenAI Massive Artificial Intelligence (AI) Deal: What Investors Should Know

On Monday, chipmaker Advanced Micro Devices (NASDAQ: AMD) announced a huge artificial intelligence (AI) strategic …

3 hours, 56 minutes ago Finance
3 Consumer Goods Stocks Set to Benefit From a Rate …

The Federal Reserve just cut interest rates. The goal was, basically, to protect the U.S. …

4 hours, 15 minutes ago Finance
2 No-Brainer Dividend Stocks to Buy and Hold Forever

If you're an income investor, or just a fan of highly valuable dividend-paying stocks, and …

4 hours, 21 minutes ago Finance
Domino's Isn't Just Selling Pizza -- It's Building Wealth

Domino's Pizza (NASDAQ: DPZ) may be best known for its 30-minute delivery promise, but for …

4 hours, 27 minutes ago Finance
Latest Articles
LG & Tata Capital scream for attention in a crowded IPO market. Which is a better investment for you?
LG & Tata Capital scream for attention in a crowded …

LG Electronics India and Tata Capital have launched significant IPOs, collectively worth over Rs 27,000 …

1 hour, 44 minutes ago Finance
WeWork India IPO Day 3: Check GMP, subscription status and key details. Should you apply?
WeWork India IPO Day 3: Check GMP, subscription status and …

WeWork India IPO: The Grey Market Premium (GMP) is currently hovering around 0.77% above the …

1 hour, 50 minutes ago Finance

Advertisement